Table of Content

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validations
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Clinical Trial Analysis
5.1. Ongoing Clinical Trials
5.2. Completed Clinical Trials
5.3. Terminated Clinical Trials
5.4. Breakdown of Pipeline, By Development Phase
5.5. Breakdown of Pipeline, By Status
5.6. Breakdown of Pipeline, By Study Type
5.7. Breakdown of Pipeline, By Region
5.8. Clinical Trials Heat Map
6. Global Malaria Therapeutics Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Drug Type (Artemisinin-based combination therapy (ACT), Quinine, Chloroquine, Others)
6.2.2. By Drug Formulation (Tablets, Capsules, Injectables, Others)
6.2.3. By Distribution Channel (Retail pharmacies, Hospitals, Online pharmacies)
6.2.4. By Region
6.2.5. By Company (2022)
6.3. Product Map
5.3.1 By Drug Type
5.3.2 By Drug Formulation
5.3.5 By Distribution Channel
5.3.6 By Region
7. North America Malaria Therapeutics Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Drug Type (Artemisinin-based combination therapy (ACT), Quinine, Chloroquine, Others)
7.2.2. By Drug Formulation (Tablets, Capsules, Injectables, Others)
7.2.3. By Distribution Channel (Retail pharmacies, Hospitals, Online pharmacies)
7.2.4. By Country
7.3. North America: Country Analysis
7.3.1. United States Malaria Therapeutics Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Drug Type
7.3.1.2.2. By Drug Formulation
7.3.1.2.3. By Distribution Channel
7.3.2. Canada Malaria Therapeutics Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Drug Type
7.3.2.2.2. By Drug Formulation
7.3.2.2.3. By Distribution Channel
7.3.3. Mexico Malaria Therapeutics Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Drug Type
7.3.3.2.2. By Drug Formulation
7.3.3.2.3. By Distribution Channel
8. Europe Malaria Therapeutics Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Drug Type (Artemisinin-based combination therapy (ACT), Quinine, Chloroquine, Others)
8.2.2. By Drug Formulation (Tablets, Capsules, Injectables, Others)
8.2.3. By Distribution Channel (Retail pharmacies, Hospitals, Online pharmacies)
8.2.4. By Country
8.3. Europe: Country Analysis
8.3.1. France Malaria Therapeutics Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Drug Type
8.3.1.2.2. By Drug Formulation
8.3.1.2.3. By Distribution Channel
8.3.2. Germany Malaria Therapeutics Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Drug Type
8.3.2.2.2. By Drug Formulation
8.3.2.2.3. By Distribution Channel
8.3.3. United Kingdom Malaria Therapeutics Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecasty
8.3.3.2.1. By Drug Type
8.3.3.2.2. By Drug Formulation
8.3.3.2.3. By Distribution Channel
8.3.4. Italy Malaria Therapeutics Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Drug Type
8.3.4.2.2. By Drug Formulation
8.3.4.2.3. By Distribution Channel
8.3.5. Spain Malaria Therapeutics Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Drug Type
8.3.5.2.2. By Drug Formulation
8.3.5.2.3. By Distribution Channel
9. Asia-Pacific Malaria Therapeutics Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Drug Type (Artemisinin-based combination therapy (ACT), Quinine, Chloroquine, Others)
9.2.2. By Drug Formulation (Tablets, Capsules, Injectables, Others)
9.2.3. By Distribution Channel (Retail pharmacies, Hospitals, Online pharmacies)
9.2.4. By Country
9.3. Asia-Pacific: Country Analysis
9.3.1. India Malaria Therapeutics Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Drug Type
9.3.1.2.2. By Drug Formulation
9.3.1.2.3. By Distribution Channel
9.3.2. Japan Malaria Therapeutics Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Drug Type
9.3.2.2.2. By Drug Formulation
9.3.2.2.3. By Distribution Channel
9.3.3. South Korea Malaria Therapeutics Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Drug Type
9.3.3.2.2. By Drug Formulation
9.3.3.2.3. By Distribution Channel
9.3.4. Australia Malaria Therapeutics Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Drug Type
9.3.4.2.2. By Drug Formulation
9.3.4.2.3. By Distribution Channel
9.3.5. Indonesia Malaria Therapeutics Market Outlook
9.3.5.1. Market Size & Forecast
9.3.5.1.1. By Value
9.3.5.2. Market Share & Forecast
9.3.5.2.1. By Drug Type
9.3.5.2.2. By Drug Formulation
9.3.5.2.3. By Distribution Channel
9.3.6. Vietnam Malaria Therapeutics Market Outlook
9.3.6.1. Market Size & Forecast
9.3.6.1.1. By Value
9.3.6.2. Market Share & Forecast
9.3.6.2.1. By Drug Type
9.3.6.2.2. By Drug Formulation
9.3.6.2.3. By Distribution Channel
9.3.7. Myanmar Malaria Therapeutics Market Outlook
9.3.7.1. Market Size & Forecast
9.3.7.1.1. By Value
9.3.7.2. Market Share & Forecast
9.3.7.2.1. By Drug Type
9.3.7.2.2. By Drug Formulation
9.3.7.2.3. By Distribution Channel
10. South America Malaria Therapeutics Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Drug Type (Artemisinin-based combination therapy (ACT), Quinine, Chloroquine, Others)
10.2.2. By Drug Formulation (Tablets, Capsules, Injectables, Others)
10.2.3. By Distribution Channel (Retail pharmacies, Hospitals, Online pharmacies)
10.2.4. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Malaria Therapeutics Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Drug Type
10.3.1.2.2. By Drug Formulation
10.3.1.2.3. By Distribution Channel
10.3.2. Colombia Malaria Therapeutics Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Drug Type
10.3.2.2.2. By Drug Formulation
10.3.2.2.3. By Distribution Channel
11. Middle East and Africa Malaria Therapeutics Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Drug Type (Artemisinin-based combination therapy (ACT), Quinine, Chloroquine, Others)
11.2.2. By Drug Formulation (Tablets, Capsules, Injectables, Others)
11.2.3. By Distribution Channel (Retail pharmacies, Hospitals, Online pharmacies)
11.2.4. By Country
11.3. MEA: Country Analysis
11.3.1. South Africa Malaria Therapeutics Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Drug Type
11.3.1.2.2. By Drug Formulation
11.3.1.2.3. By Distribution Channel
11.3.2. Saudi Arabia Malaria Therapeutics Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Drug Type
11.3.2.2.2. By Drug Formulation
11.3.2.2.3. By Distribution Channel
11.3.3. UAE Malaria Therapeutics Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Drug Type
11.3.3.2.2. By Drug Formulation
11.3.3.2.3. By Distribution Channel
11.3.4. Turkey Malaria Therapeutics Market Outlook
11.3.4.1. Market Size & Forecast
11.3.4.1.1. By Value
11.3.4.2. Market Share & Forecast
11.3.4.2.1. By Drug Type
11.3.4.2.2. By Drug Formulation
11.3.4.2.3. By Distribution Channel
11.3.5. Egypt Malaria Therapeutics Market Outlook
11.3.5.1. Market Size & Forecast
11.3.5.1.1. By Value
11.3.5.2. Market Share & Forecast
11.3.5.2.1. By Drug Type
11.3.5.2.2. By Drug Formulation
11.3.5.2.3. By Distribution Channel
11.3.6. Nigeria Malaria Therapeutics Market Outlook
11.3.6.1. Market Size & Forecast
11.3.6.1.1. By Value
11.3.6.2. Market Share & Forecast
11.3.6.2.1. By Drug Type
11.3.6.2.2. By Drug Formulation
11.3.6.2.3. By Distribution Channel
12. Market Dynamics
12.1. Drivers
12.1.1 High prevalence of malaria
12.1.2 Growing Awareness
12.2. Challenges
12.2.1 High Cost and not always readily available
12.2.2 Lack of Public Awareness
13. Market Trends & Developments
13.1. Use of digital therapeutics
13.2. Increasing use of genetic testing
13.3. Increasing use of Combination Therapies
14. Global Malaria Therapeutics Market: SWOT Analysis
15. Porter’s Five Forces Analysis
15.1. Competition in the Industry
15.2. Potential of New Entrants
15.3. Power of Suppliers
15.4. Power of Customers
15.5. Threat of Substitute Products
16. Competitive Landscape
16.1. Business Overview
16.2. Product Offerings
16.3. Recent Developments
16.4. Financials (As Reported)
16.5. Key Personnel
16.6. SWOT Analysis
16.6.1. Novartis AG
16.6.2. Sanofi S.A
16.6.3. Pfizer Inc
16.6.4. GlaxoSmithKline Plc
16.6.5. Merck & Co Inc
16.6.6. F. Hoffmann-La Roche AG
16.6.7. Medicines for Malaria Venture
16.6.8. 60? Pharmaceuticals, Inc
16.6.9. Cipla Limited
16.6.10. Ajanta Pharma Limited
17. Strategic Recommendations
18. About Us & Disclaimer